Cerebral Assessment Systems, Inc.
Country not established
- Devices
- 1
What Cerebral Assessment Systems, Inc. makes
Cerebral Assessment Systems, Inc. manufactures COGNIVUE, a cognitive assessment device designed for evaluating neurocognitive function in clinical settings.
The device is classified as Class II under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Cognivue Ref DEN130033
Regimes: De Novo Registry: De Novo
Frequently asked questions
How many devices does Cerebral Assessment Systems, Inc. have in the registry?
The registry currently lists 1 device for Cerebral Assessment Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cerebral Assessment Systems, Inc.'s devices?
Among its 1 most recently registered device, Cerebral Assessment Systems, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Cerebral Assessment Systems, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Cerebral Assessment Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cerebral Assessment Systems, Inc. in the registry?
The most recently registered devices listed for Cerebral Assessment Systems, Inc. include COGNIVUE.